Doxirobe
Withdrawn
This medicine's authorisation has been withdrawn
doxycycline
MedicineVeterinaryWithdrawn
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for Doxirobe has not been renewed by the marketing authorisation holder and is now withdrawn.
Product information
01/12/2003
Product details
- Name of medicine
- Doxirobe
- Active substance
- doxycycline
- International non-proprietary name (INN) or common name
- doxycycline
- Species
- Dogs
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QJ01AA02
Pharmacotherapeutic group
Antibacterials for systemic useTherapeutic indication
Treatment of periodontal disease in dogs.
Periodontal pocket probing depths >=4 mm are evidence of disease that may be responsive to treatment with the Doxirobe Gel. Use of this product as directed should result in attachment level gains, periodontal pocket depth reductions, local antimicrobial effect and improved gingival health. Noticeable improvements in these parameters should be evident within 2-4 weeks following treatment. The response in individual dogs is dependent on the severity of the condition and rigor of adjunctive therapy.
This page was last updated on